These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 6373297

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [The use of a tripeptide chromogenic substrate for simultaneous determination of 4 indices of kallikrein-kinin system].
    Dotsenko VL, Iarovaia GA, Neshkova EA.
    Vopr Med Khim; 1989; 35(2):128-33. PubMed ID: 2741408
    [Abstract] [Full Text] [Related]

  • 44. Plasma kallikrein and plasmin as activators of prorenin: links between the renin-angiotensin system and other proteolytic systems in plasma.
    Schalekamp MA, Derkx FH.
    Clin Sci (Lond); 1981 Jul; 61(1):15-21. PubMed ID: 6454526
    [No Abstract] [Full Text] [Related]

  • 45. [Changes in the proteolytic activity and components of the blood kallikrein-kinin system during the growth and metastasis of experimental neoplasms].
    Veksler IG, Veremeenko KN, Riabukha VN, Pogorelaia NF, Balitskiĭ KP.
    Eksp Onkol; 1986 Jul; 8(3):65-7. PubMed ID: 3522198
    [Abstract] [Full Text] [Related]

  • 46. Chromogenic substrate assays for studying components of the plasma kallikrein system in health and disease.
    Gallimore MJ.
    Adv Exp Med Biol; 1983 Jul; 156():225-31. PubMed ID: 6552839
    [No Abstract] [Full Text] [Related]

  • 47. The use of chromogenic substrates for the determination of kallikrein and other serine proteases in plasma and synovial fluid in man.
    Lewis DH, Bengtsson MB, Liljedahl SO, Larsson J.
    Adv Biosci; 1978 Jul 22; 17():163-71. PubMed ID: 158556
    [No Abstract] [Full Text] [Related]

  • 48. Antithrombin III, plasminogen, plasmin, and alpha-2-antiplasmin in donor blood and plasma components.
    McRoyan DK, McRoyan CJ, Sauter KL, Liu PI, Daniel SJ.
    Ann Clin Lab Sci; 1985 Jul 22; 15(2):165-70. PubMed ID: 3158265
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Synthetic peptide substrates in hemostatic testing.
    Fareed J, Messmore HL, Walenga JM, Bermes EW.
    Crit Rev Clin Lab Sci; 1983 Jul 22; 19(2):71-134. PubMed ID: 6373139
    [Abstract] [Full Text] [Related]

  • 52. Serine protease specificity for peptide chromogenic substrates.
    Mattler LE, Bang NU.
    Thromb Haemost; 1977 Dec 15; 38(4):776-92. PubMed ID: 146272
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Oral contraceptives and fibrinolysis among female cyclists before and after exercise.
    Huisveld IA, Hospers AJ, Bernink MJ, Biersteker MW, Erich WB, Bouma BN.
    J Appl Physiol Respir Environ Exerc Physiol; 1982 Aug 15; 53(2):330-4. PubMed ID: 7118654
    [Abstract] [Full Text] [Related]

  • 55. Circulating levels of prekallikrein and kallikrein in pregnancy and labor.
    Sayama S, Kashiwagi H, Ogawa T, Terada K, Soma H, Kato M.
    Int J Biol Res Pregnancy; 1981 Aug 15; 2(2):90-4. PubMed ID: 6916725
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.